Talks & Presentations

2019


Glyco25 International Symposium on Glycoconjugates - Milan, Italy - August 25-31, 2019

Advancements in glycoanalytical strategies for quantitative N- and O-glycan analysis from in-vitro established cell lines.

Maximilianos Kotsias

CarboMet Training Workshop - Leiden, Netherlands - July 5, 2019

Creating and Using Glycans in Precision Work - 1 day workshop

Organised and led by Jenifer Hendel and Daniel Spencer

XXth European Carbohydrate Symposium (EUROCARB) 2019 - Leiden, Netherlands - June 30-July 4, 2019

Linkage-specific Characterization of Sialylated N-glycans from Human Plasma by LC-MS

Alan Moran

14th Congress of ECCO - Inflammatory Bowel Diseases 2019 - Copenhagen, Denmark - March 6-9, 2019

Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease

Archana Shubhakar

Marie Curie ITN Nanocarb Symposium - Milan, Italy - May 2019

Glycan roles in Biopharmaceuticals and Precision Medicine

Daniel Spencer


2018


11th European Biosimilars Congress: Euro Biosimilars 2018 - Rome, Italy - April 26-27, 2018

Automated Permethylation for Glycosylation Analysis of Biologics Using MALDI-TOF-MS

Archana Shubhakar


2017


5th Annual Congress of AnalytiX 2017 - Fukuoka, Japan - March 22-24, 2017

Automated High-Throughput Permethylation for Glycosylation Analysis Using MALDI-TOF-MS

Archana Shubhakar


2016


GlycoPar workshop - Liverpool, UK - September 12-15, 2016

Analysis of Erythropoietin Glycosylation

Dr Daniel Spencer

GlycoPar workshop - Liverpool, UK - September 12-15, 2016

Procainamide labelling: part of a sensitive workflow for the identification and quantitation of potential glycan drug targets by HILIC-HPLC-ESI-MS/MS

Dr Katherine Wongtrakul-Kish

GlycoPar workshop - Liverpool, UK - September 12-15, 2016

First steps in the development of a high throughput method for O-glycosylation analysis

Maximilianos Kotsias

37th BMSS Annual Meeting - Eastbourne, UK - September 13-15, 2016

Biopharmaceutical erythropoietin characterisation: critical quality attribute (CQA) mapping using LC-ESI-Qtof and automated database searching of glycopeptide and glycan analytes

Radoslaw Kozak

IgG meeting - Dubrovnik, Croatia - June 2016

30 Years of IgG Glycosylation and Disease: The Oxford-Tokyo RA Study

Dr Daryl Fernandes

Series of presentations to biopharmaceutical developers - China - April 2016

Drug Glycoprofiling: What the most successful biopharma companies do to satisfy the Regulators and outpace their competitors

Dr Daryl Fernandes

Metrology of Carbohydrates - Brussels, Belgium - 18th February 2016

Industry perspective for glycan needs

Dr Daniel Spencer

Glycobiotechnology 2016 - Manchester, UK - 4th & 5th April 2016

A profile of Ludger Ltd

Dr Daniel Spencer


2015


Presentation to the China FDA(CFDA) - Shanghai, China - April 3, 2015

Assessing the regulatory significance of changes in biopharmaceutical glycosylation

Dr Daryl Fernandes

Series of presentations to biopharmaceutical developers - Wuhan, Zhuhai, Guangzhou and Shenyang, China - March 20-28, 2015

Demonstrating comparability of drug glycosylation, and what Glycosylation Critical Quality Attribute need to be taken into consideration for Drugs quality control

Dr Daryl Fernandes


2014


11th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2014), CASSS - Napa, CA, USA - September 9-14, 2014

Reliability of a semi-automated, High Throughput (HT) MS based glycomics system for discovery of glycan biomarkers and Quality by Design (QbD) studies of glycoprotein therapeutics

Archana Shubhakar

10th European Symposium on Saliva - Egmond aan Zee, The Netherlands - May 14-17, 2014

Saliva glycosylation analysis

Radoslaw P. Kozak

GlycoComparability of Biosimilars Workshop - Shanghai, China - April 8, 2014

Assessing the regulatory significance of changes in biopharmaceutical glycosylation with reliable glycometrics

Dr Daryl Fernandes

Waters Biopharmaceutical Analysis Symposium - Elstree, UK- March 27, 2014

Selecting the Most Appropriate Analytical Methods for Glycosylation Analysis of Specific Glycoproteins

Dr Louise Royle

Presentation to the FDA - Bethesda, Maryland USA - January 31, 2014

Assessing the regulatory significance of changes in biopharmaceutical glycosylation with reliable glycometrics

Dr Daryl Fernandes


2013


World Biopharm Forum 2013, Continuous Processing in Biopharmaceutical Manufacturing - Cambridge, UK - July 1, 2013

Correction of out-of-specification drug glycosylation during continuous processing

Dr Louise Royle

XXII International Symposium on Glycoconjugates - Dalian, China - June 25, 2013

Improved O-glycan Analysis Methods

Radoslaw P. Kozak


2012


International GlycomicsSymposium - San Sebastien, Spain - July 19-21, 2012

Ludger - A Glycoprofiling Bridge Between Academia and Biopharma

Dr Daniel Spencer